Skip to main content

Table 2 Mean absorbed dose per administered activity [Gy/GBq] in normal tissues and bone metastases estimated by the three dosimetry methods

From: Comparison of different methods for post-therapeutic dosimetry in [177Lu]Lu-PSMA-617 radioligand therapy

Mean dose [Gy/GBq] 2D Hybrid 3D
Parotid gland 0.75 ± 0.34 0.81 ± 0.34 0.81 ± 0.34
Submandibular gland 0.71 ± 0.36 0.73 ± 0.39 0.72 ± 0.39
Kidneys 0.49 ± 0.31 0.52 ± 0.27 0.54 ± 0.28
Liver 0.09 ± 0.04 0.10 ± 0.05 0.10 ± 0.05
Bone metastases 1.42 ± 0.99 1.55 ± 1.28 1.68 ± 1.32